P. Downs

Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man.

L. Braverman, K. Sterling, A. Vagenakis, 1973, The Journal of clinical investigation.

Decreased post-heparin lipases in Graves's disease.

L. Braverman, R. Arky, P. Schreibman, 1972, The New England journal of medicine.

An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.

G. Ellard, P. Jenner, P. Downs, 1980, British journal of clinical pharmacology.

Control of thyroid hormone secretion in normal subjects receiving iodides.

L. Braverman, A. Burger, A. Vagenakis, 1973, The Journal of clinical investigation.

Factors motivating dyspepsia patients to enter clinical research.

M. Rojavin, M. Shetzline, P. Downs, 2006, Contemporary clinical trials.

Randomized, Double-Blind, Parallel-Group, 48-Week Study for Efficacy and Safety of a Higher-Dose Rivastigmine Patch (15 vs. 10 cm2) in Alzheimer’s Disease

J. Molinuevo, J. Cummings, R. Kressig, 2012, Dementia and Geriatric Cognitive Disorders.

A Phase 1/2 Study of Quizartinib (Q) in Combination with Re-Induction Chemotherapy and As Single-Agent Continuation Therapy in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) FLT3-ITD Acute Myeloid Leukemia (AML)

A. DeCillis, C. Zwaan, E. Kolb, 2019, Blood.